Sturm, Ruger & Company, Inc. (RGR)
USD 35.58
(-1.74%)
USD 35.58
(-1.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 33.9 Million | 77.23 Million | 172.33 Million | 143.8 Million | 49.58 Million | 119.81 Million |
| Net Income | 48.21 Million | 88.33 Million | 155.89 Million | 90.39 Million | 32.29 Million | 50.93 Million |
| Depreciation & Amortization | 22.38 Million | 25.78 Million | 26.15 Million | 27.57 Million | 29.33 Million | 31.97 Million |
| Deferred income taxes | -5.86 Million | -5.57 Million | 994 Thousand | 3.86 Million | -2.42 Million | -4.37 Million |
| Stock-based compensation | 3.98 Million | 1.67 Million | 8.28 Million | 6.12 Million | 6.33 Million | 5.8 Million |
| Change in working capital | -36.12 Million | -33.45 Million | -19.81 Million | 15.89 Million | -17.04 Million | 35.66 Million |
| Other non-cash items | 1.3 Million | 465 Thousand | 826 Thousand | -52 Thousand | 1.1 Million | -195 Thousand |
| Investing Cash Flow | 40.85 Million | 13.2 Million | -107.53 Million | -43.88 Million | -35.44 Million | -124.79 Million |
| Investments in PPE | -15.79 Million | -27.73 Million | -28.77 Million | -24.22 Million | -20.29 Million | -10.54 Million |
| Acquisitions | 5000.00 | 100 Thousand | 203 Thousand | 178 Thousand | 14 Thousand | 10 Thousand |
| Investment purchases | -192.62 Million | -365.48 Million | -681.94 Million | -369.43 Million | -282.73 Million | -114.25 Million |
| Sales/Maturities of investments | 249.27 Million | 406.31 Million | 602.97 Million | 377.92 Million | 267.57 Million | - |
| Other Investing Activities | 5000.00 | 100 Thousand | 203 Thousand | -28.31 Million | 14 Thousand | 10 Thousand |
| Financing Cash Flow | -124.75 Million | -46.31 Million | -63.9 Million | -115.19 Million | -17.21 Million | -20.01 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -110.78 Million | -42.71 Million | -59.1 Million | -113.89 Million | -14.31 Million | -19.2 Million |
| Common Stock Repurchased | -11.81 Million | -222 Thousand | -4.8 Million | -1.29 Million | -2.89 Million | -816 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.15 Million | -3.37 Million | -4.8 Million | -1.29 Million | -901 Thousand | -816 Thousand |
| Accounts receivables | 5.58 Million | -8.41 Million | 840 Thousand | -5.23 Million | -7.6 Million | 15.05 Million |
| Accounts payables | -4.03 Million | -640 Thousand | -392 Thousand | 7.95 Million | -3.64 Million | 939 Thousand |
| Inventory | -16.12 Million | -21.64 Million | -15.72 Million | 10.62 Million | 2.07 Million | 8.47 Million |
| Other working capital | -21.54 Million | -2.75 Million | -4.53 Million | 2.55 Million | -7.85 Million | 11.19 Million |
| Cash at beginning of period | 65.17 Million | 21.04 Million | 20.14 Million | 35.42 Million | 38.49 Million | 63.48 Million |
| Cash at end of period | 15.17 Million | 65.17 Million | 21.04 Million | 20.14 Million | 35.42 Million | 38.49 Million |
| Capital Expenditure | -15.79 Million | -27.73 Million | -28.77 Million | -24.22 Million | -20.29 Million | -10.54 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -49.99 Million | 44.12 Million | 897 Thousand | -15.27 Million | -3.07 Million | -24.99 Million |
| Free Cash Flow | 18.1 Million | 49.5 Million | 143.56 Million | 119.57 Million | 29.29 Million | 109.27 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.73 Million | 8.26 Million | 7.08 Million | 48.21 Million | 10.24 Million | 7.43 Million |
| Depreciation & Amortization | 5.8 Million | 5.3 Million | 5.83 Million | 22.38 Million | 2.8 Million | 6.53 Million |
| Deferred income taxes | -191 Thousand | 365 Thousand | -3.11 Million | -5.86 Million | -1.8 Million | -108 Thousand |
| Stock-based compensation | 1.09 Million | 1.07 Million | 1.08 Million | 3.98 Million | 1.02 Million | 1.02 Million |
| Change in working capital | -2.55 Million | 4.2 Million | -3.53 Million | -36.12 Million | 3.02 Million | -19.38 Million |
| Other non-cash items | 506 Thousand | 6.59 Million | 9.44 Million | 1.3 Million | 1.3 Million | -2000.00 |
| Investing Cash Flow | 3.25 Million | -7.63 Million | 1.21 Million | 40.85 Million | -193 Thousand | 12.99 Million |
| Investments in PPE | -6.78 Million | -8.62 Million | -1.78 Million | -15.79 Million | -4.15 Million | -6.76 Million |
| Acquisitions | - | - | - | 5000.00 | -3.96 Million | 2000.00 |
| Investment purchases | -24.58 Million | -36.92 Million | -39.48 Million | -192.62 Million | -51.21 Million | -23.43 Million |
| Sales/Maturities of investments | 34.61 Million | 37.91 Million | 42.48 Million | 249.27 Million | 55.18 Million | 43.19 Million |
| Other Investing Activities | - | 996 Thousand | 2.99 Million | 5000.00 | 3.96 Million | 2000.00 |
| Financing Cash Flow | -12.28 Million | -19.76 Million | -7.92 Million | -124.75 Million | -14.79 Million | -6.38 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -3.2 Million | -2.7 Million | -4.08 Million | -110.78 Million | -2.98 Million | -6.38 Million |
| Common Stock Repurchased | -9.07 Million | -17.05 Million | -3.21 Million | -11.81 Million | -11.81 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -624 Thousand | -2.15 Million | -2.98 Million | -88.34 Million |
| Accounts receivables | -4.03 Million | 9.69 Million | -5.95 Million | 5.58 Million | 35 Thousand | -6.83 Million |
| Accounts payables | 2.25 Million | -713 Thousand | -2.05 Million | -4.03 Million | 2.96 Million | -313 Thousand |
| Inventory | -3.21 Million | -4.36 Million | 11.31 Million | -16.12 Million | -1.84 Million | -9.85 Million |
| Other working capital | 2.43 Million | -410 Thousand | -6.84 Million | -21.54 Million | 1.88 Million | -2.38 Million |
| Cash at beginning of period | 7.15 Million | 15.8 Million | 15.17 Million | 65.17 Million | 13.55 Million | 11.45 Million |
| Cash at end of period | 7.52 Million | 7.15 Million | 15.8 Million | 15.17 Million | 15.17 Million | 13.55 Million |
| Capital Expenditure | -6.78 Million | -8.62 Million | -1.78 Million | -15.79 Million | -4.15 Million | -6.76 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 369 Thousand | -8.65 Million | 633 Thousand | -49.99 Million | 1.61 Million | 2.1 Million |
| Free Cash Flow | 2.61 Million | 10.11 Million | 5.55 Million | 18.1 Million | 12.44 Million | -11.27 Million |
0KEJ
MEDICAB
1419
8031
RDWR
4575